Focusing on major innovative vaccines with independent intellectual property rights.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 11, 2020 | Series B | ¥1.50B | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
HT Capital | — | Series B |
China Everbright Investment Management | — | Series B |